Similar sites
Category
PharmacyGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
#medication
#pharmaceutical
#januvia
#januvia coupon
#diabetes
#dbmscan
Category
InvestingGlobal Rank
N/ARank in 1 month
9KEstimate Value
N/ASorry. Description is not currently available
Malware Scan Info
Macafee Check : 
Email address with januxrx.com
Recent Searched Sites
Backoffice.makro.co.za (11 seconds ago) / IE
Vent.at (1 mins ago) / AT
Meineinkaufsbummel.de (3 seconds ago) / DE
Youth.conservatives.com (2 seconds ago) / US
Januxrx.com (1 seconds ago) / US
Resilientco.net (36 seconds ago) / CA
Fragboss.com (2 seconds ago) / CA
Cityuniversity.ca (16 seconds ago) / US
Sedind.com (25 seconds ago) / CN
Kronenhotel-seefeld-in-tirol.hotelmix.it (3 seconds ago) / US
Hubsideline.com (4 seconds ago) / US
Hotel-wbf-shijokarasuma-kyoto.hotelmix.co.uk (13 seconds ago) / US
Casa-camper-barcelona-hotel.nochi.com (10 seconds ago) / US
Akoonu.com (21 seconds ago) / DE
Pyramids-park-resort-cairo.ibooked.fr (3 seconds ago) / US
Gainsboroughgalleries.com (6 seconds ago) / US
Amperman.com (24 seconds ago) / DK
Hoteltaimar.com (6 seconds ago) / FR
Uais.cr.ktu.lt (16 seconds ago) / LT
Minhkhuetravel.com (1 seconds ago) / US
Domain Informations
Januxrx.com lookup results from whois.godaddy.com server:
- Domain created: 2020-03-10T17:14:54Z
- Domain updated: 2023-03-15T16:34:07Z
- Domain expires: 2026-03-10T17:14:54Z 1 Year, 188 Days left
- Website age: 4 Years, 175 Days
- Registrar Domain ID: 2501898199_DOMAIN_COM-VRSN
- Registrar Url: http://www.godaddy.com
- Registrar WHOIS Server: whois.godaddy.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 480-624-2505
- Name server:
- NS47.DOMAINCONTROL.COM
- NS48.DOMAINCONTROL.COM
Network
- inetnum : 141.193.213.0 - 141.193.213.255
- name : WPENG
- handle : NET-141-193-213-0-1
- status : Direct Allocation
- created : 2020-03-20
- changed : 2020-07-14
Owner
- organization : WPEngine, Inc.
- handle : WPENG
- address : Array,Austin,TX,78701,US
Abuse
- handle : ABUSE7875-ARIN
- name : Abuse
- phone : +1-512-273-3906
- email : [email protected]
Technical support
- handle : ADMIN7400-ARIN
- name : Admin
- phone : +1-877-973-6446
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 682459 |
| namecheap.com | 226280 |
| networksolutions.com | 167026 |
| tucows.com | 138054 |
| publicdomainregistry.com | 86591 |
| whois.godaddy.com | 62081 |
| enomdomains.com | 58049 |
| cloudflare.com | 51575 |
| namesilo.com | 48435 |
| gmo.jp | 46514 |
| register.com | 38825 |
| fastdomain.com | 38013 |
| ionos.com | 33965 |
| wildwestdomains.com | 32128 |
| name.com | 31938 |
| registrar.amazon.com | 30730 |
| net.cn | 30663 |
| dynadot.com | 28794 |
| key-systems.net | 27094 |
Host Informations
| Host name | 141.193.213.21 |
| IP address | 141.193.213.21 |
| Location | United States |
| Latitude | 37.751 |
| Longitude | -97.822 |
| Timezone | America/Chicago |
Port Scanner (IP: 141.193.213.21)
Spam Check (IP: 141.193.213.21) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Keyword Suggestion
Site Inspections
Websites Listing
We found Websites Listing below when search with januxrx.com on Search Engine
Janux Therapeutics - Crunchbase Company Profile
Legal Name Janux Therapeutics, Inc. Stock Symbol NASDAQ:JANX. Company Type For Profit. Phone Number 858-750-4700. Janux Therapeutics develops immunotherapies that generate immune responses to prevent tumors and not affecting a patient’s healthy tissue. Janux technology targets all three stages of the anti-tumor immune response.
Crunchbase.comDA: 18 PA: 32 MOZ Rank: 50
Janux Therapeutics - Overview, News & Competitors
Janux Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated …
Zoominfo.comDA: 16 PA: 31 MOZ Rank: 48
Janux Therapeutics to Present at 2022 Jefferies Global …
SAN DIEGO, June 02, 2022--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, today announced that Janux management will present …
Ca.finance.yahoo.comDA: 20 PA: 50 MOZ Rank: 84
Working at Janux Therapeutics | Glassdoor
Scientist Interview. Anonymous Employee in La Jolla, CA. Accepted Offer. Positive Experience. Average Interview. Application. I applied online. The process took 3 days. I interviewed at Janux Therapeutics (La Jolla, CA) in Apr 2022.
Glassdoor.comDA: 17 PA: 50 MOZ Rank: 82
Janux Therapeutics Appoints Ron Barrett, Ph.D., and Alana
For more information, please visit www.januxrx.com. Forward-Looking Statements. This news release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking …
Ca.finance.yahoo.comDA: 20 PA: 50 MOZ Rank: 84
Janux Therapeutics Provides Business Update and Reports Fourth …
Janux Therapeutics, Inc. Condensed Statements of Operations and Comprehensive Loss (in thousands, except share and per share data) Three Months Ended December 31, Year Ended December 31, 2021
Businesswire.comDA: 20 PA: 50 MOZ Rank: 45
Janux Therapeutics Appoints Ron Barrett, Ph.D., and Alana …
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its prop
Businesswire.comDA: 20 PA: 50 MOZ Rank: 44
JANX: Janux Therapeutics Inc - Stock Price, Quote and News - CNBC
Get Janux Therapeutics Inc (JANX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Cnbc.comDA: 12 PA: 12 MOZ Rank: 31
Janux Therapeutics Inc (JANX) Stock Price & News - Google Finance
Get the latest Janux Therapeutics Inc (JANX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Google.comDA: 14 PA: 26 MOZ Rank: 48
Stockwatch
Janux is developing a broad pipeline with lead TRACTr programs targeting prostate-specific membrane antigen (PSMA), epidermal growth factor receptor (EGFR), and trophoblast cell surface antigen 2 (TROP2). For more information, please visit www.januxrx.com.
Stockwatch.comDA: 18 PA: 50 MOZ Rank: 78
2021-09-09 | NDAQ:JANX | Press Release | Janux Therapeutics Inc.
( | NDAQ:JANX) Janux Therapeutics Appoints Ron Barrett, Ph.D., and Alana McNulty to Board of Directors
Stockhouse.comDA: 14 PA: 50 MOZ Rank: 40
Janux Therapeutics to Present Preclinical Data at the 18th Annual …
For more information, please visit www.januxrx.com. Forward-Looking Statements This news release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements.
Firstwordpharma.comDA: 19 PA: 14 MOZ Rank: 44
JANX Stock Price & Charts | Janux Therapeutics
Janux Therapeutics GAAP EPS of -$0.33 misses by $0.02, revenue of $1.62M beats by $0.97M. SA Breaking News. 03/18 16:06. Janux Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results. Yahoo. 03/18 16:01. Janux Therapeutics to Present at Upcoming March Investor Conferences.
Ycharts.comDA: 11 PA: 15 MOZ Rank: 38
Janux Therapeutics to Present Preclinical Data at the 18th Annual …
For more information, please visit www.januxrx.com. Forward-Looking Statements. This news release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking …
Apnews.comDA: 10 PA: 50 MOZ Rank: 37
Janux Therapeutics to Present Virtually at the H.C. Wainwright 23rd ...
SAN DIEGO, September 07, 2021--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, today announced that Janux management …
Ca.movies.yahoo.comDA: 19 PA: 50 MOZ Rank: 87
Janux Therapeutics : Successful $222.9 million IPO in June brings …
-Successful $222.9 million IPO in June brings total funds raised in the quarter to $347.9 million- -Company on-track to submit IND filings for multiple programs in 2022- ... | June 17, 2022
Marketscreener.comDA: 22 PA: 50 MOZ Rank: 35
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|